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Endoluminal Negative-Pressure Therapy
for Preventing Rectal Anastomotic Leaks:
A Pilot Study in a Pig Model
Amber L. Shada,1 Laura H. Rosenberger,1 Mark J. Mentrikoski,2 Michael A. Silva,3
Sanford H. Feldman,4 and Daniel E. Kleiner 5

Abstract

Background: Anastomotic leak after rectal resection carries substantial morbidity and mortality. A diverting
ileostomy is beneficial for high-risk anastomoses, but its creation and reversal carry a surgical risk in addition to
that of resection itself. We sought an alternative method for managing complications of rectal anastomosis.
Methods: We developed an endoluminal negative-pressure technology with a diverting proximal sump, and
hypothesized that it would close anastomotic disruptions in pigs. We performed rectal resections on pigs, with
primary anastomoses and the creation of an anastomotic defect. In animals in the treatment group we inserted an
endoluminal negative-pressure device and kept it at a low level of continuous suction for 5 d. No device was
inserted in a control group of animals. After the 5-d period of treatment we evaluated the anastomoses in both the
treatment and control groups of animals for leakage, using contrast enemas. Specimens of anastomosed rectum
were evaluated histologically for mucosal integrity and for the location and density of inflammatory responses.
Results: Fourteen pigs were assigned to either the treatment (n = 10) or control (n = 4) group. Of the pigs in the
treatment group, 90% had complete closure of their rectal defect, as compared with 25% of the animals in the
control group (w2 test, p = 0.04). The animals in the treatment group had only minimal mucosal and serosal
inflammation, whereas those in the control group had extensive mucosal damage with associated serositis.
Conclusions: Endoluminal negative-pressure therapy was well-tolerated and led to successful closure of 90% of
the anastomic rectal defects in the treatment group of animals in the present study. Additional evaluation of this
therapy is warranted.

C

olorectal cancer remains the third most common
cancer in both men and women, and follows lung cancer
as the second leading cause of cancer-related death. Of the
estimated 149,000 cases of colorectal cancer in the United
States in 2008, 28% were rectal [1]. The American Cancer Society predicted approximately 39,870 new cases of rectal
cancer in 2011 [2]. Operative therapy remains the mainstay of
curative treatment for rectal cancer. Commonly, an anterior
resection with primary anastomosis is performed with or
without temporary proximal diversion. The use of abdominal
perineal resection and a permanent stoma for treating rectal
cancer has decreased over time [3].
Anastomotic disruption is a dreaded complication of colorectal surgery, leading to increases in re-operation rates,
hospital lengths of stay, cancer recurrence rates, morbidity,
and mortality [4–6]. Anastomotic leaks may result in ab-

scesses, enterocutaneous fistulae, severe sepsis, and peritonitis. Although the reported overall rate of leaks in colorectal
anastomoses ranges from 2.4%–12%, a markedly higher rate
of anastomotic disruption, of 8%–24%, occurs in lower rectal
anastomoses [5,7–10]. Proximal diversion through loop
ileostomy or transverse colostomy does not prevent anastomotic leaks and is therefore not commonly used other than for
high-risk anastomoses [7,9]. Classic management of an anastomotic leak requires laparotomy and resection or reinforcement of the anastomosis, with proximal diversion or creation
of a Hartmann pouch [5]. A proximal diversion without resection of the leaking anastomosis may be a safe alternative
[9,11]
Regardless of the technique used for its management, an
anastomotic leak requires additional surgical procedures in
both the short-term and remotely to restore bowel continuity,
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with each surgical procedure incurring additional morbidity
and surgical risk. Morbidity is also associated with enterostomies, and loop ileostomies carry among the highest rates
of stomal morbidity [12]. We therefore sought an alternative to the surgical management of anastomotic leaks in the
rectum.
Morykwas et al. introduced negative-pressure therapy in
1997 as a method to expedite healing by secondary intention
[13]. They conducted multiple animal experiments involving
the introduction of their vacuum-assisted closure (VAC) device with a foam dressing, adhesive drape, and controlled
subatmospheric pressure to accelerate wound healing. They
found that the VAC technique increased local blood perfusion, accelerated granulation-tissue formation, decreased tissue bacterial loads, and increased nutrient blood flow [13,14].
Additionally, VAC therapy decreases local inflammation [15].
Vacuum-assisted closure devices now have numerous
clinical applications and have recently been used in treating
pre-sacral and para-anastomotic rectal abscesses. The EndoSPONGE (B. Braun Medical, Melsungen, Germany), a VAC
device commercially available in Europe, is effective in closing abscess cavities resulting from anastomotic leakage
without the need for re-operation [16–21]. The technique for
this uses an endoscope to reach the abscess cavity, a plastic
introducer tube, and pushing probe to deploy the EndoSPONGE into the abscess cavity while the plastic tube is retracted [16]. The technique requires exchange of the device
every 3 –4 d and approximately one month for full resolution
of the cavity.
Our study proposed a novel technique in which a negativepressure closure device placed within the bowel lumen is used
to heal anastomotic leaks in the rectum following a low anterior resection. This endoluminal technique also provides a
proximal sump port to eliminate waste. We conducted a nonrandomized, controlled trial in a pig survival model to test the
use of endoluminal negative-pressure therapy for the healing
of anastomotic leaks following rectal resection and for reducing leak-related morbidity by reducing rates of intraabdominal sepsis. Our secondary endpoint was to evaluate
mucosal integrity and inflammation at the leak site.
Materials and Methods
The Institutional Animal Care and Use Committee (IACUC) at the University of Virginia approved the study. Our
protocol ensured the appropriate care, use, and humane
treatment of the animals being used for research in accordance
to the Animal Welfare Act of 1966 (as amended in 1990) and
the Guide for the Care and Use of Laboratory Animals [22, 23].
Pig characteristics and operative preparation
Our study used 14 female Yorkshire pigs (60 lb–80 lb each).
Upon arrival in our vivarium, pigs were kept under standard
husbandry conditions, fed a Teklad 7037 Miniswine diet
(Harlan Laboratories, Indianapolis, IN) and allowed to acclimate for 72 h. Food was withheld for 48 h before surgery and
pigs were provided ad libitum access to drinking water containing sucrose at 50 g/L. At 24 h before surgery pigs were
given 24 fluid ounces of magnesium citrate either in their
drinking water or via gastric intubation under brief anesthesia
for preoperative bowel preparation and washout.
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Anesthesia and surgical approach
On the day of surgery anesthesia was induced in the study
animals with intramuscular (IM) xylazine 2 mg/kg and telazol 6 mg/kg. When the animals were in the recumbent position for surgery, they were given glycopyrrolate IM at
0.01 mg/kg, long-acting tetracycline (LA-200, Pfizer, New
York, NY) IM at 9 mg/kg, and enrofloxacin (Baytril 100,
Bayer, Morristown, NJ) IM at 7.5 mg/kg. The animals were
intubated, maintained under anesthesia with 2.5% isoflurane
in oxygen, and monitored with standard cardiopulmonary
monitoring. Warm lactated Ringer’s solution (LRS) was administered intravenously (IV) during surgery at 5 mL/kg/h
and animals were placed on a circulating-warm–water blanket to prevent hypothermia. The neck, back, and abdomen of
each animal were shaved and the skin prepared for aseptic
surgery. A transdermal fentanyl patch (75 mcg/h) was placed
on the thoracic skin and 0.3 mg buprenorphine IV was administered once. The pigs were prepped and draped in the
usual sterile fashion and an indwelling silastic catheter (0.062’’
ID x 0.125’’ OD) was implanted in the internal jugular vein
and tunneled subcutaneously to exit caudal to the ipsilateral
scapula. A midline lower abdominal incision was then made
and the peritoneal cavity was entered sharply. The rectosigmoid colon was mobilized and approximately 5 cm of
rectum was resected in the standard fashion. The distal colon
was primarily re-anastomosed to the rectum using a curved
21-mm ENDOPATH endoscopic intraluminal circular stapler
(Ethicon Endo-Surgery, Inc, Cincinnati, OH). A 2-cm defect
was then made sharply in the staple line in each pig, leaving a
visible gap in the colorectal anastomosis (Fig. 1).
The pigs were assigned to either the study or the control
group. Before surgery on each pig was begun, it was scheduled
to facilitate the availability of necessary equipment, including
suction and fluoroscopy equipment. Pigs in the study group
underwent placement of a negative-pressure system with a
dual-chamber sump (Fig. 2). This was made with black GranuFoam (Kinetic Concepts, Inc, San Antonio, TX) arranged cylindrically around 16-French sump tubes (Bard Medical,
Covington, GA). The negative-pressure system was placed
manually into the rectum of each animal in the study group,
across the site of anastomosis. The proximal sump port terminated in the colon proximal to the site of anastomosis, and was
connected to a suction unit at negative pressures of 5–140 mm
Hg. The distal vacuum port terminated within the GranuFoam
sponge and was connected to a separate vacuum system with
negative pressures of 5–140 mm Hg. The tubing exited into the
perirectal tissues and was tunneled subcutaneously and exteriorized posterior to the scapula. This was done to facilitate minimal restraint of the animals. The anus was sewed shut with silk
suture. The abdomen of each pig was closed with running sutures of #1 polydiaxinone and the skin was closed with staples.
Postoperative care
Postoperative continuous total parenteral nutrition (TPN)
and LRS was given to the study animals via a central line. The
animals’ resting energy requirement (RER) was calculated as
35 kcal/kg/day, with 80% of their calories provided by fat
(Liposyn II, Hospira, Lake Forest, IL) and 20% by glucose
(50% glucose, Butler-Schein, Melville, NY). Amino acids were
supplemented at 4 g/100 kcal/d (10% amino acid, Aminosynsulfite free, Hospira) and the potassium concentration of the
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FIG. 1. After rectal resection and stapled anastomosis, a 2-cm enterotomy was made in the staple line in all of the pigs in the
study. In the treatment group of pigs, the negative-pressure device was placed across the defect. A portion of the device can
be seen through the defect (arrow). Color image is available online at www.liebertpub.com/sur

infusate was adjusted to 30 mEq/L. Total parenteral nutrition was given at a rate calculated to deliver the animals’
RER over a period of 24 h and LRS was provided at 1 mL/
kg/h. Serum biochemistry analyses was done on postoperative days 1 and 5 to assess hepatic and renal function
and to determine whether the animals were hydrated adequately. During the period between surgery and euthanasia,
the study animals were placed in a harness (Lomir Biomedical, Malone, NY) with a conduit to protect IV and vacuum
lines, and their motion was restrained partly with a harness
that prevented them from turning but allowed them to stand
and move with restriction in an 18 ft2 elevated run. The pigs
were tranquilized twice daily with a combination of 5 mg
diazepam/10 mg acetylpromazine IV to facilitate measurement of their temperature, pulse, and respiration, and their
physical examination by members of the veterinary staff. Pigs
exhibiting signs of peritonitis, which included tachycardia
(heart rate [HR] > 150 beats/min), peritoneal signs, fever
( > 103.5 F), or discomfort that was not relieved with

fentanyl or buprenorphine, were removed from the study and
euthanized.
Macroscopic evaluation
Pigs were weighed pre-operatively and after euthanasia. On
post-operative day 5 pigs were euthanized with Euthasol (Virbac, Fort Worth, TX), the endoluminal negative-pressure system
was removed in the study group, and post-mortem lower GI
fluoroscopy with contrast (50% Hypaque, diluted 1:5; Amersham Health, Princeton, NJ) was done and recorded on an OEC
8800 C-arm fluoroscope (GE Medical Systems, Salt Late City,
UT). At necropsy, the animals’ exploratory laparotomies were
re-opened and the peritoneal cavity examined for evidence of
peritonitis, abscess, anastomotic fistulae, and adhesions.
Histopathology
The sites of rectal anastomosis in each animal were excised
and fixed in formalin. The specimens were dissected, and
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mucosal inflammation, moderate representing increased inflammation with loss of mucosal crypts, and severe representing complete absence of crypts. Serositis was scored as
mild if minimal serosal inflammation was present and as
moderate if inflammation and fibrinous adhesions were seen.
Adhesions to any adjacent abdominal organs were recorded.
The pathologist was blinded as to which specimens came
from pigs in the control and which from pigs in the treatment
group of the study.
Statistical analysis
The study was a feasibility study and its original intent was
not to provide statistical significance but to evaluate the feasibility of using the endoluminal negative-pressure device
investigated in the study. The study was not statistically
powered a priori. The Fisher exact test was used to calculate
statistical differences in the frequency of leaks in the control
and treatment groups in the study.
Results
Gross evaluation and fluoroscopy

FIG. 2. Top: Schematic diagram of the endoluminal negative-pressure device, illustrating the proximal sump (arrow
1) and the vacuum device with its separate vacuum tubing
(arrow 2). Middle: Photograph of the negative-pressure device ex vivo, showing black Granufoam, adhesive moisture
barrier, and sump and vacuum tubing. Bottom: Photograph
of the external portion of the tubing system of the device,
showing fluid drained by the vacuum sponge (red) and fluid
from the proximal fecal sump (yellow-brown). Color image
is available online at www.liebertpub.com/sur
sections of the enterotomy site, uninvolved rectum, and any
areas of atypical appearance were taken for examination. The
sections were embedded in paraffin, cut at 5-mm intervals
with a standard microtome, mounted on slides, and stained
with hematoxylin and eosin (H&E). The slides were evaluated
by a pathologist (M.M.) for mucosal integrity, overall inflammatory response, and the presence of serositis, mucosal
necrosis, and fibrinous adhesions. Inflammatory response
was evaluated adjacent to the enterotomy site and graded as
mild, moderate, or severe, with mild representing increased

Ten pigs had an endoluminal negative-pressure device
placed colorectally and were part of the experimental group.
All 10 tolerated 5 d of therapy. Nine of these animals had
complete closure on post-mortem fluoroscopy (Fig. 3). One had
a contained leak near the site of anastomosis, with a 5-cm abscess on necropsy. We did not see any leak on gross necropsy in
the nine pigs with complete healing (Fig. 4). In seven pigs, a
scar was seen at the anastomosis, with complete apposition of
rectal mucosa. No physiologic narrowing of the lumen was
seen on fluoroscopy. In two cases, adjacent structures (bladder,
fallopian tube, ovary) had formed a flap over the anastomotic
site to create the seal (Fig. 5).
The four pigs in the control group did not undergo endoluminal negative-pressure therapy. Three of these pigs had a
leak at the site of anastomosis on fluoroscopy and turbid fluid
in the abdomen on necropsy (Fig. 3). Two of these three pigs
contained leaks with abscesses adjacent to the anastomoses.
One pig had an uncontained leak, with free enteric contents in
the abdomen. Three of the four pigs had to be removed from
the study due to signs of sepsis. Thus, the p value for postoperative leak in this pilot study is 0.04.
Weight and laboratory tests
Control pigs weighed an average of 27 kg at the beginning
of the study and 28 kg at its conclusion. The mean weight of
the pigs in the treatment group was 30 kg at both the beginning and the end of the study. The white blood cell (WBC)
count in the control group averaged 10.9 k/mm3 at the beginning, and increased to 19.1 by the end of the study. WBC
count in the experimental group averaged 18.8 k/mm3 at the
beginning and 26.7 k/mm3 at the end of the study. Serum
biochemical analysis found no significant difference between
the control and treatment groups during the study.
Histopathology
Representative histology specimens from both the treatment and the control groups are shown in Figure 6. All enterotomy sites showed standard microscopic reparative

FIG. 3. Left: Representative fluoroscopic image of rectal anatomosis in a control pig. Contrast medium flows freely from the
site of anastomosis (arrow) into the pelvis. Right: Contrast-enhanced fluoroscopic image of anastomosis in a pig in the group
treated with the endoluminal negative-pressure device, showing an intact rectal anastomosis.

FIG. 4. Top: Gross necropsy of specimen of rectum (R) with adjacent bladder (B). Bottom: The specimen is shown after
lengthwise opening, revealing an intact anastomosis (arrow). Color image is available online at www.liebertpub.com/sur
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FIG. 5. Top row: Gross histology demonstrating the rectum with adjacent, adherent fallopian tube (on left). On the right, the
rectum is opened lengthwise to reveal an intact anastomosis, with a flap of adjacent serosa as a patch. Bottom row: Adhesion
of rectum to surrounding abdominal organs (H&E, 20 · magnification). Fibrinous adhesion of the enterotomy site and
surrounding rectum to various abdominal organs was observed in both control and experimental pigs, including bladder (A),
ovary (B), and fallopian tube (C). Arrows indicate the site of organ adhesion to rectum. Prominent inflammation was minimal
in the surrounding organs. Color image is available online at www.liebertpub.com/sur

changes, including increased acute and chronic inflammation
and granulation tissue with early scar formation. Use of the
endoluminal device was associated with decreased rates of
mucosal inflammation and crypt dropout in the treatment as
compared with the control group (26% vs. 75%, respectively),
decreased rates of prominent serositis (46% vs. 75%, respectively), and decreased ischemia/mucosal necrosis adjacent to
the enterotomy site (27% vs. 100%, respectively) (Table 1).
Fibrinous adhesions with involvement of surrounding abdominal organs (bladder, ovary, and fallopian tubes) were
seen frequently in both the treatment and control groups (64%
vs. 75%, respectively ). One pig in the control group that was
found to have a leak showed extensive microscopic damage

to the rectum, including extensive necrosis and prominent
submucosal hemorrhage.
Discussion
The study described here examined in a prospective manner the ability of endoluminal negative-pressure therapy to
close leaks in colorectal anastomoses. Endoluminal negativepressure therapy was well tolerated in the pigs in which it was
examined in the study, and successfully closed 90% of colorectal anastomoses in the study subgroup of animals in which
it was used. The leaks created in these animals ranged in size
from one-third to one-half of the bowel lumen, and were

FIG. 6. (A-C) Photomicrographs of rectal tissues of a representative pig in the control group following enterotomy showing
(A) prominent transmural ischemic changes at the site of enterotomy (A, arrow). Extensive inflammation and serosal
hemorrhage. (D–F) Minimal edema and inflammation in surrounding mucosa, as well as adjacent to the enterotomy site, are
seen in these photomicrographs following enterotomy in a representative animal in the treatment group. Even the enterotomy site itself had minimal surrounding mucosal inflammation (F, arrow). An adjacent lymph node (LN). Color image is
available online at www.liebertpub.com/sur
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Table 1. Summary of Histologic Findings in Rectal
Specimens of Pigs Treated with Encoluminal
Negative-Pressure Device and Controls
following Rectal Anastomosis

growing, and unable to tolerate being NPO for several days,
in contrast to adult human beings following surgery.
Grossly and histologically, we saw adhesions between the
rectum and adjacent structures after anastomosis in the animals in our study. Published data link negative-pressure
therapy to the formation of enterocutaneous fistulas. This is of
concern in view of the morbidity associated with rectovaginal
and rectovesicular fistulas. The minimal inflammation seen
on histology in our study animals is somewhat reassuring,
indicating that use of the negative-pressure device examined
in the study is a potentially inconsequential process. Additionally, there was no difference in the rate of formation of
adhesions in the control and treatment groups in our study.
This finding is reassuring, but this issue bears further investigation in follow-up studies.
Anastomotic leak continues to be a substantial cause of
morbidity and mortality after rectal surgery. Risk factors for
anastomotic complications include rectal operations, patients
with several co-morbidities, radiation, immunosuppression,
and emergency surgery [4,10]. Anastomotic leaks in cancer
patients undergoing colorectal surgery are also associated
with decreased cancer-specific survival as well as local recurrence of disease [6,22]. There are obvious differences between high-risk anastomoses in human beings, such as those
in patients in whom irradiation of the pelvis is used in treating
rectal cancer. This factor has not been addressed with our
current model, and further evaluation of anastomoses created
after irradiation is needed for examination of their histologic
and other features.
The present study has shown that 5 d of endoluminal
negative-pressure therapy assists the closure of anastomotic
leaks. This pilot study did not evaluate the long-term durability of rectal anastomoses after endoluminal negativepressure therapy. To begin assessing the durability of these
anastomoses after removal of the negative-pressure device,
we conducted a follow-up ‘‘survival’’ study of the anastomoses created in the study at 14 days after removal of the
device. In this follow up we studied two pigs with the protocol described in the Methods section of this paper, but rather
than performing euthanasia and necropsy on post-operative
day 5, we allowed the pigs to resume eating for 14 d after
removal of the negative-pressure device. We then performed
repeat fluoroscopic evaluations at 14 d after removal of the
pigs’ devices and found that neither pig had a leak or narrowing of their anastomosis on fluoroscopy. The duration of
application of the device needed for complete healing is not
known, and may vary with the individual patient. In our
study the device was placed transrectally with direct visualization. Conceivably, the device could also be placed endoscopically, allowing replacement if it became dislodged or
dysfunctional during the course of treatment. This was not
attempted in the present study.
Previous studies have evaluated use of negative-pressure
wound therapy in the healing of anastomotic leaks. Several
studies have evaluated the Endo-SPONGE system [20,21],
and another study, by Mees et al., examined an endovacuum
assisted-closure device that significantly accelerated wound
healing after colorectal surgery [17]. Patients treated with the
devices described in these studies required diverting ostomies
before the devices were placed. In contrast, our study evaluated the use of endoluminal therapy rather than diversion
with the use of a proximal stoma.

Inflammation
Minimal
Mild
Moderate
Adhesions
Ischemia/necrosis

Control (n = 4)

VAC (n = 9)

0
25%
75%
75%
100%

18%
64%
27%
64%
27%

VAC = vacuum-assisted closure device.

found to have healed fully on fluoroscopic examination and
necropsy. None of the animals undergoing negative-pressure
wound therapy had signs of intra-abdominal infection. Animals in the control group did not do as well, as we expected in
view of their large untreated enterotomies. The frequency of
leaks in the treatment group as determined fluoroscopically
was significantly lower than that in the control group, even in
this small pilot study.
We propose the use of a negative-pressure device to assist
the healing of colorectal anastomoses expected to carry a high
risk of post-operative leakage. A diverting proximal stoma,
although protective against morbidity after rectal surgery,
also creates issues of morbidity, cost, and quality of life for the
patient. As is a diverting ileostomy, a negative-pressure device would be used to prevent a potential leak from becoming
clinically important. We believe that use of a post-operative
endoluminal negative-pressure device may serve as a prophylactic measure in high-risk colorectal anastomoses, and
could potentially replace diverting loop ileostomy in select
cases. This could change the way in which rectal surgery is
performed, and provide a means of preventing and managing
the complications of anastomotic leaks without the need for a
diverting ostomy.
In this study we chose to create artificially an incomplete
staple line because we believed that closing a known leak
would more reliably demonstrate, in a smaller group of animals, the success of the device examined in the study. An
alternative study design, with the negative-pressure device
examined in the study placed in an intact anastomosis, would
find a probable leak rate of 15% (as estimated from the rates of
leak after low anterior resection), and would thus require a
larger study population. The small sample size and nonrandomized design of the present study permit only preliminary conclusions to be drawn from the study data, and a
larger scale study will be beneficial. The method in which the
device was inserted in the pigs in the present study (tunneled
subcutaneously, exiting through perianal tissue) was part of
the study design largely because pigs scratch their perianal
areas and would otherwise dislodge the device with their
movement. We do not anticipate these issues with human
studies, in which we intend to have the negative-pressure
device examined in the present study exit just as would a
rectal tube. With the vacuum suction applied to the device, it
undergoes virtually no migration. This is similar to the case
with commercially available negative-pressure systems for
wound therapy. We also do not anticipate that human studies
would include the need for TPN and NPO. We used TPN in
the pigs in the present study because they were young and
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We conclude that endoluminal negative-pressure therapy
is feasible and safe in an animal model. This therapy was
successful in closing anastomotic defects in 90% of the animals in which it was used in our study. Even in this small
population, the rate of anastomotic leak was significantly
lower with use of the endoluminal device. Additional
evaluation of endoluminal negative-pressure therapy is
warranted in a larger study, and examination in human
clinical trials of the device described in the present study is
warranted.
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